Provided by Tiger Trade Technology Pte. Ltd.

Gilead Sciences

143.49
-1.2500-0.86%
Volume:511.19K
Turnover:73.55M
Market Cap:178.03B
PE:-54.87
High:145.16
Open:143.21
Low:143.21
Close:144.74
52wk High:157.29
52wk Low:109.66
Shares:1.24B
Float Shares:1.24B
Volume Ratio:0.73
T/O Rate:0.04%
Dividend:3.22
Dividend Rate:2.24%
EPS(TTM):-2.6150
EPS(LYR):6.78
ROE:-20.68%
ROA:14.09%
PB:15.05
PE(LYR):21.16

Loading ...

One Molecule, Three Diseases, $1.55 Billion — Inside CSL's Bet

Bellwether Stocks Movement
·
6 hours ago

Merck Doubled Off Its Lows — And Analysts Still See More Room

Bellwether Stocks Movement
·
7 hours ago

CSL Bets $1.6 Billion on a Drug That Hasn't Finished Phase 2

Bellwether Stocks Movement
·
11 hours ago

Nurix, Gilead Extend Research Term for Oncology Program by Two Years for $10 Million Fee

Reuters
·
3 hours ago

Nurix Extends Gilead Collaboration for Oncology Program

Reuters
·
3 hours ago

Nurix - Eligible for up to $1.30 Bln in Total Payments as of May 31, 2026

THOMSON REUTERS
·
3 hours ago

Nurix - Eligible for Mid-Single-Digit to Low-Teens Percentage Tiered Royalties

THOMSON REUTERS
·
3 hours ago

Nurix - to Receive $10 Mln Research Term Extension Fee

THOMSON REUTERS
·
3 hours ago

Nurix - Retains Co-Development and 50/50 Profit Sharing Options on Two U.S. Programs

THOMSON REUTERS
·
3 hours ago

Bayer Bets $2.2 Billion That America Is Still The Best Place To Make Drugs

Macro World​
·
Oct 03

23.3% Vs 14.8%: Lilly's New Data Just Changed The Obesity Drug Playbook

Bellwether Stocks Movement
·
Oct 03

Gilead CEO Daniel O’Day Disposes of USD 2,216,507.50 in Common Shares

Reuters
·
Oct 03

Gilead Sciences Inc. Stock Underperforms Friday When Compared to Competitors

Dow Jones
·
Oct 03

Legend Biotech Faces Pressure From Rivals Ahead of Key FDA Decision, UBS Says

MT Newswires Live
·
Oct 03

Novartis Bets $7.8 Billion On MRNA Beyond Vaccines

Options & Short Sell
·
Oct 02

More Upside Awaits for Gilead Sciences Stock. Stay Invested.

Dow Jones
·
Oct 02

Gilead Sciences Announces Dividend of R$ 0.2394442440 Per Unit for Brgildbdr 000

Reuters
·
Oct 01

Vir Biotechnology Names Aziz Sawaf as CFO Effective Oct. 5, 2026

Reuters
·
Oct 01

Gilead Sciences Inc. Stock Underperforms Wednesday When Compared to Competitors

Dow Jones
·
Oct 01

Moderna Inc. Stock Sheds 5.4%, Underperforms Peers

Dow Jones
·
Oct 01